Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ABBOTT LABORATORIES

(ABT)
  Report
Delayed Nyse  -  04:03 2022-12-09 pm EST
107.51 USD   +0.55%
04:04pAbbott Laboratories : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
11:07aAbbott Laboratories Lifts Quarterly Dividend to $0.51 a Share, Payable Feb. 15 to Shareholders as of Jan. 13
MT
10:50aAbbott Increases Quarterly Dividend, Marking 51 Consecutive Years of Dividend Growth
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

US FDA Commits to Strengthening Infant Formula Supply

09/20/2022 | 02:55pm EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES 0.55% 107.51 Delayed Quote.-25.53%
PERRIGO COMPANY PLC -1.77% 31.55 Delayed Quote.-17.43%
All news about ABBOTT LABORATORIES
04:04pAbbott Laboratories : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin..
AQ
11:07aAbbott Laboratories Lifts Quarterly Dividend to $0.51 a Share, Payable Feb. 15 to Share..
MT
10:50aAbbott Increases Quarterly Dividend, Marking 51 Consecutive Years of Dividend Growth
PR
12/02Reckitt expects U.S. infant formula shortage until spring
RE
12/01Reckitt expects U.S. infant formula shortage until spring
RE
12/01Enfamil maker Reckitt sees formula shortage continuing until Spring
RE
11/25Ypsomed, CamDiab Roll Out Automated Insulin Dosing on Abbott's Glucose Monitoring Syste..
MT
11/21Abbott Launches Panbio HIV Self Test at Retail, Increasing Access to Faster, Reliable a..
CI
11/17Abbott Receives Three CES 2023 Innovation Awards for Advancements in Health Technology
PR
11/10Becton Dickinson expects fiscal 2023 COVID test sales to drag
RE
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Financials (USD)
Sales 2022 43 181 M - -
Net income 2022 6 845 M - -
Net Debt 2022 4 483 M - -
P/E ratio 2022 27,8x
Yield 2022 1,74%
Capitalization 187 B 187 B -
EV / Sales 2022 4,44x
EV / Sales 2023 4,75x
Nbr of Employees 113 000
Free-Float 87,2%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 107,51 $
Average target price 116,15 $
Spread / Average Target 8,03%
EPS Revisions
Managers and Directors
Robert B. Ford Chairman, President, Chief Executive Officer & COO
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Glenn Fletcher Tilton Independent Director
William A. Osborn Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES-25.53%186 423
MEDTRONIC PLC-25.65%103 475
BECTON, DICKINSON AND COMPANY0.29%70 269
DEXCOM, INC.-12.16%47 382
AMERISOURCEBERGEN CORPORATION28.14%35 059
HOYA CORPORATION-21.68%34 966